Company profile: InVivo Biotech Services
1.1 - Company Overview
Company description
- Provider of contract manufacturing services for development and production of monoclonal antibodies and recombinant proteins. Offerings include antibody production from hybridomas (small to large scale), recombinant protein expression in bacterial and mammalian systems, non-GMP cell line development, research antibodies produced in HEK under serum-free conditions, and SARSβCoVβ2 antigens and antibodies for immunoassays.
Products and services
- Antibody Production: Constructs monoclonal antibodies from hybridoma cells with small- and large-scale runs under ISO 9001-certified processes, serving varied volumes within mammalian cell culture and protein production programs
- Cell Line Development: Develops stable cell lines for non-GMP applications, suitable for research and diagnostic purposes, leveraging mammalian cell culture expertise
- Recombinant Protein Production: Produces recombinant proteins using bacterial and mammalian expression systems with ISO 9001-certified operations, supporting contracted protein expression as a leading CMO
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to InVivo Biotech Services
Saladax Biomedical
HQ: United States
Website
- Description: Provider of therapeutic drug monitoring assays and services for psychiatry and oncology, including MyCare Psychiatry for rapid blood level measurement of antipsychotic drugs and MyCare Oncology for rapid therapeutic drug level testing to assist treatment plans; also offers application sheets for measuring clozapine, olanzapine, quetiapine, and total risperidone using Beckman Coulter systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Saladax Biomedical company profile β
Variantyx
HQ: United States
Website
- Description: Provider of molecular diagnostics specializing in advanced genetic testing: PCR-free whole genome sequencing for uniform coverage and detection of clinically relevant variants; IriSight tests for SNVs, indels, structural, repeat expansions, mitochondrial variants; Genomic Intelligence analytical software; OncoAlly tumor profiling using WGS, WES and RNA; and ClaudIA for Genomics producing actionable reports for cancer treatment management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Variantyx company profile β
ReadCoor
HQ: United States
Website
- Description: Provider of the first true spatial multi-omic platform (RC2) that simultaneously detects and reads sequences, serving a global audience of researchers, clinicians, pharma and diagnostics companies to expand understanding of human biology and facilitate the creation of new therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full ReadCoor company profile β
Tocris Bioscience
HQ: United Kingdom
Website
- Description: Provider of reagents for non-clinical life science research, including TR-FRET donors (CoraFluor 2) for assay development and biomolecule labeling; selective HDAC3 degraders (JPS036) for targeted protein degradation; M5 receptor antagonists (VU 6019650); dual LAG3 interaction inhibitors (SA-15-P) for immune checkpoint research; ALDH detection substrates (BAAA-DA); and near-infrared fluorogens (SiRA 2) for RNA imaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Tocris Bioscience company profile β
Fulcrum Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapies targeting rare genetic diseases at their root cause, including losmapimod (a small molecule under investigation for facioscapulohumeral muscular dystrophy) and FTX-6058 (a small molecule designed to increase expression of fetal hemoglobin for treating sickle cell disease and beta-thalassemia).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Fulcrum Therapeutics company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for InVivo Biotech Services
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InVivo Biotech Services
2.2 - Growth funds investing in similar companies to InVivo Biotech Services
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for InVivo Biotech Services
4.2 - Public trading comparable groups for InVivo Biotech Services
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β